Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Am J Transplant ; 18(4): 998-1006, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29178588

RESUMEN

Porcine islet xenografts have the potential to provide an inexhaustible source of islets for ß cell replacement. Proof-of-concept has been established in nonhuman primates. However, significant barriers to xenoislet transplantation remain, including the poorly understood instant blood-mediated inflammatory reaction and a thorough understanding of early xeno-specific immune responses. A paucity of data exist comparing xeno-specific immune responses with alloislet (AI) responses in primates. We recently developed a dual islet transplant model, which enables direct histologic comparison of early engraftment immunobiology. In this study, we investigate early immune responses to neonatal porcine islet (NPI) xenografts compared with rhesus islet allografts at 1 hour, 24 hours, and 7 days. Within the first 24 hours after intraportal infusion, we identified greater apoptosis (caspase 3 activity and TUNEL [terminal deoxynucleotidyl transferase dUTP nick end labeling])-positive cells) of NPIs compared with AIs. Macrophage infiltration was significantly greater at 24 hours compared with 1 hour in both NPI (wild-type) and AIs. At 7 days, IgM and macrophages were highly specific for NPIs (α1,3-galactosyltransferase knockout) compared with AIs. These findings demonstrate an augmented macrophage and antibody response toward xenografts compared with allografts. These data may inform future immune or genetic manipulations required to improve xenoislet engraftment.


Asunto(s)
Modelos Animales de Enfermedad , Rechazo de Injerto/inmunología , Supervivencia de Injerto/inmunología , Inflamación/inmunología , Trasplante de Islotes Pancreáticos/inmunología , Islotes Pancreáticos/inmunología , Macrófagos/inmunología , Animales , Animales Recién Nacidos , Apoptosis , Islotes Pancreáticos/patología , Macaca mulatta , Porcinos , Trasplante Heterólogo
2.
J Med Primatol ; 47(1): 81-84, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-28671309

RESUMEN

Recrudescence of latent and dormant viruses may lead to overwhelming viremia in immunosuppressed hosts. In immunocompromised hosts, Simian virus 40 (SV40) reactivation is known to cause nephritis and demyelinating central nervous system disease. Here, we report SV40 viremia leading to fatal interstitial pneumonia in an immunosuppressed host following renal allotransplantation.


Asunto(s)
Huésped Inmunocomprometido , Enfermedades Renales/fisiopatología , Macaca mulatta , Enfermedades de los Monos/fisiopatología , Neumonía/fisiopatología , Infecciones por Polyomavirus/veterinaria , Virus 40 de los Simios/fisiología , Infecciones Tumorales por Virus/veterinaria , Animales , Enfermedades Renales/virología , Trasplante de Riñón/veterinaria , Enfermedades de los Monos/virología , Neumonía/virología , Infecciones por Polyomavirus/complicaciones , Infecciones Tumorales por Virus/complicaciones
3.
Am J Transplant ; 17(5): 1193-1203, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-27888551

RESUMEN

Costimulation blockade (CoB) via belatacept is a lower-morbidity alternative to calcineurin inhibitor (CNI)-based immunosuppression. However, it has higher rates of early acute rejection. These early rejections are mediated in part by memory T cells, which have reduced dependence on the pathway targeted by belatacept and increased adhesion molecule expression. One such molecule is leukocyte function antigen (LFA)-1. LFA-1 exists in two forms: a commonly expressed, low-affinity form and a transient, high-affinity form, expressed only during activation. We have shown that antibodies reactive with LFA-1 regardless of its configuration are effective in eliminating memory T cells but at the cost of impaired protective immunity. Here we test two novel agents, leukotoxin A and AL-579, each of which targets the high-affinity form of LFA-1, to determine whether this more precise targeting prevents belatacept-resistant rejection. Despite evidence of ex vivo and in vivo ligand-specific activity, neither agent when combined with belatacept proved superior to belatacept monotherapy. Leukotoxin A approached a ceiling of toxicity before efficacy, while AL-579 failed to significantly alter the peripheral immune response. These data, and prior studies, suggest that LFA-1 blockade may not be a suitable adjuvant agent for CoB-resistant rejection.


Asunto(s)
Abatacept/farmacología , Rechazo de Injerto/tratamiento farmacológico , Supervivencia de Injerto/inmunología , Memoria Inmunológica/inmunología , Trasplante de Riñón/efectos adversos , Antígeno-1 Asociado a Función de Linfocito/química , Linfocitos T/inmunología , Animales , Modelos Animales de Enfermedad , Tasa de Filtración Glomerular , Rechazo de Injerto/etiología , Rechazo de Injerto/patología , Supervivencia de Injerto/efectos de los fármacos , Memoria Inmunológica/efectos de los fármacos , Inmunosupresores/farmacología , Pruebas de Función Renal , Antígeno-1 Asociado a Función de Linfocito/metabolismo , Macaca mulatta , Complicaciones Posoperatorias , Linfocitos T/efectos de los fármacos , Linfocitos T/patología
4.
Am J Transplant ; 15(5): 1241-52, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25702898

RESUMEN

Islet xenotransplantation is a potential treatment for diabetes without the limitations of tissue availability. Although successful experimentally, early islet loss remains substantial and attributed to an instant blood-mediated inflammatory reaction (IBMIR). This syndrome of islet destruction has been incompletely defined and characterization in pig-to-primate models has been hampered by logistical and statistical limitations of large animal studies. To further investigate IBMIR, we developed a novel in vivo dual islet transplant model to precisely characterize IBMIR as proof-of-concept that this model can serve to properly control experiments comparing modified xenoislet preparations. WT and α1,3-galactosyltransferase knockout (GTKO) neonatal porcine islets were studied in nonimmunosuppressed rhesus macaques. Inert polyethylene microspheres served as a control for the effects of portal embolization. Digital analysis of immunohistochemistry targeting IBMIR mediators was performed at 1 and 24 h after intraportal islet infusion. Early findings observed in transplanted islets include complement and antibody deposition, and infiltration by neutrophils, macrophages and platelets. Insulin, complement, antibody, neutrophils, macrophages and platelets were similar between GTKO and WT islets, with increasing macrophage infiltration at 24 h in both phenotypes. This model provides an objective and internally controlled study of distinct islet preparations and documents the temporal histology of IBMIR.


Asunto(s)
Inflamación/inmunología , Trasplante de Islotes Pancreáticos/métodos , Islotes Pancreáticos/citología , Animales , Animales Modificados Genéticamente , Glucemia/química , Plaquetas/inmunología , Activación de Complemento , Modelos Animales de Enfermedad , Galactosiltransferasas/genética , Inmunohistoquímica , Macaca mulatta , Macrófagos/inmunología , Neutrófilos/inmunología , Fenotipo , Porcinos , Factores de Tiempo , Trasplante Heterólogo
5.
Pediatr Transplant ; 18(2): E57-63, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24438382

RESUMEN

The most common identifiable causes of acute liver failure in pediatric patients are infection, drug toxicity, metabolic disease, and autoimmune processes. In many cases, the etiology of acute liver failure cannot be determined. Acute leukemia is an extremely rare cause of acute liver failure, and liver transplantation has traditionally been contraindicated in this setting. We report a case of acute liver failure in a previously healthy 15-yr-old male from pre-B-cell acute lymphoblastic leukemia. He underwent liver transplantation before the diagnosis was established, and has subsequently received chemotherapy for pre-B-cell acute lymphoblastic leukemia. He is currently alive 31 months post-transplantation. The published literature describing acute lymphoblastic leukemia as a cause of acute liver failure is reviewed.


Asunto(s)
Leucemia de Células B/complicaciones , Leucemia de Células B/terapia , Fallo Hepático Agudo/complicaciones , Fallo Hepático Agudo/cirugía , Trasplante de Hígado , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicaciones , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Adolescente , Biopsia , Humanos , Inmunosupresores/uso terapéutico , Hígado/patología , Pruebas de Función Hepática , Masculino , Donantes de Tejidos , Resultado del Tratamiento
6.
Am J Transplant ; 13(3): 808-10, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23331705

RESUMEN

Posterior reversible encephalopathy syndrome (PRES) is a small vessel microangiopathy of the cerebral vasculature that occurs in 0.5-5% of solid organ transplant recipients, most commonly associated with tacrolimus (Tac). Clinical manifestations include hypertension and neurologic symptoms. We report an adult multivisceral transplant recipient who experienced recurrent PRES initially associated with Tac and subsequently with sirolimus. A 49-year-old woman with short bowel syndrome underwent multivisceral transplantation due to total parenteral nutrition-related liver disease. She was initially maintained on Tac, mycophenalate mofetil (MMF) and prednisone. Three months after transplantation, she developed renal dysfunction, leading to a reduction in Tac and the addition of sirolimus. Eight months after transplantation, she developed PRES. Tac was discontinued and PRES resolved. Sirolimus was increased to maintain trough levels of 12-15 ng/mL. Fourteen months after transplant, she experienced recurrent PRES which resolved after discontinuing sirolimus. Currently 3 years posttransplant, she is maintained on cyclosporine, MMF and prednisone with no PRES recurrence. In addition to calcineurin inhibitors, sirolimus may also be associated with PRES after solid organ transplantation. Ours is the first report of sirolimus-associated PRES in the setting of multivisceral transplantation. Identifying a safe alternative immunosuppression regimen was challenging but ultimately successful.


Asunto(s)
Rechazo de Injerto/tratamiento farmacológico , Hepatopatías/cirugía , Trasplante de Hígado/efectos adversos , Síndrome de Leucoencefalopatía Posterior/inducido químicamente , Complicaciones Posoperatorias/prevención & control , Sirolimus/efectos adversos , Tacrolimus/efectos adversos , Femenino , Rechazo de Injerto/inducido químicamente , Humanos , Inmunosupresores/efectos adversos , Persona de Mediana Edad , Síndrome de Leucoencefalopatía Posterior/tratamiento farmacológico , Pronóstico , Recurrencia
7.
Am J Transplant ; 12(8): 2242-6, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22594310

RESUMEN

Restoring abdominal wall cover and contour in children undergoing bowel and multivisceral transplantation is often challenging due to discrepancy in size between donor and recipient, poor musculature related to birth defects and loss of abdominal wall integrity from multiple surgeries. A recent innovation is the use of vascularized posterior rectus sheath to enable closure of abdomen. We describe the application of this technique in two pediatric multivisceral transplant recipients--one to buttress a lax abdominal wall in a 22-month-old child with megacystis microcolon intestinal hypoperistalsis syndrome and another to accommodate transplanted viscera in a 10-month child with short bowel secondary to gastoschisis and loss of domain. This is the first successful report of this procedure with long-term survival. The procedure has potential application to facilitate difficult abdominal closure in both adults and pediatric liver and multivisceral transplantation.


Asunto(s)
Anomalías Múltiples/cirugía , Seudoobstrucción Intestinal/cirugía , Trasplante de Órganos , Colon/anomalías , Colon/cirugía , Femenino , Humanos , Lactante , Masculino , Trasplante Homólogo , Vejiga Urinaria/anomalías , Vejiga Urinaria/cirugía
8.
Am J Transplant ; 10(9): 2161-7, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20883549

RESUMEN

Two patients developed renal mucormycosis following transplantation of kidneys from the same donor, a near-drowning victim in a motor vehicle crash. Genotypically, indistinguishable strains of Apophysomyces elegans were recovered from both recipients. We investigated the source of the infection including review of medical records, environmental sampling at possible locations of contamination and query for additional cases at other centers. Histopathology of the explanted kidneys revealed extensive vascular invasion by aseptate, fungal hyphae with relative sparing of the renal capsules suggesting a vascular route of contamination. Disseminated infection in the donor could not be definitively established. A. elegans was not recovered from the same lots of reagents used for organ recovery or environmental samples and no other organ transplant-related cases were identified. This investigation suggests either isolated contamination of the organs during recovery or undiagnosed disseminated donor infection following a near-drowning event. Although no changes to current organ recovery or transplant procedures are recommended, public health officials and transplant physicians should consider the possibility of mucormycosis transmitted via organs in the future, particularly for near-drowning events. Attention to aseptic technique during organ recovery and processing is re-emphasized.


Asunto(s)
Trasplante de Riñón/efectos adversos , Mucormicosis/mortalidad , Mucormicosis/transmisión , Ahogamiento Inminente/complicaciones , Accidentes de Tránsito , Adolescente , Adulto , Femenino , Humanos , Riñón/microbiología , Riñón/patología , Masculino , Inutilidad Médica , Persona de Mediana Edad , Mucorales/aislamiento & purificación , Mucormicosis/etiología , Mucormicosis/patología , Ahogamiento Inminente/etiología , Ahogamiento Inminente/terapia , Recolección de Tejidos y Órganos/efectos adversos , Trasplante Homólogo
9.
Eur J Clin Invest ; 38(8): 596-602, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18717828

RESUMEN

BACKGROUND: Chronic aspiration associated with gastro oesophageal reflux disease (GERD) is thought to play a substantial role in the development of asthma, the incidence of which is dramatically increasing in industrially developed countries. The majority of data examining the association between aspiration and asthma has been obtained from epidemiological studies, which show that between 50 and 90% of individuals with asthma experience some element of GERD. This study describes the effect of chronic aspiration on a model of experimentally induced airway hypersensitivity in Balb/c mice. MATERIALS AND METHODS: Four experimental groups were utilized: Aspiration/Asthma, Sham/Asthma, Aspiration/Sham and Sham/Sham. Mice were sensitized with aerosolized 1% ovalbumin on days 1 to 10 (sensitization phase), followed by repeated exposure on days 31 to 40 (challenge phase). Aspiration events occurred on days 1, 8,15, 22, 29, 36, 43 and 50. Animals were sacrificed on days 56 and 57. RESULTS: Chronic aspiration of 10 microL of murine gastric fluid per week for eight weeks produced an injury pattern distinct from that of acute aspiration, with lung injury characterized by hyperplasia, neutrophil infiltration of the bronchioles and relative parenchymal sparing. Aspiration during induction of ovalbumin-induced airway hypersensitivity was associated with a trend toward decreased production of antiovalbumin IgG, antiovalbumin IgE, and total IgE. Further, aspiration induced a substantial and significant increase in antiovalbumin IgG1/IgG2a ratios, consistent with a shift toward a predominantly Th2 response. CONCLUSION: These findings indicate that chronic aspiration has a profound effect on the nature of the immune response to aerosolized allergens in a model of experimentally induced airway hypersensitivity.


Asunto(s)
Asma/inmunología , Hiperreactividad Bronquial/inmunología , Líquido del Lavado Bronquioalveolar/química , Citocinas/análisis , Inmunoglobulina E/inmunología , Animales , Broncoconstrictores/administración & dosificación , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Femenino , Pulmón/patología , Ratones , Ovalbúmina/administración & dosificación
10.
HPB (Oxford) ; 10(1): 25-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18695755

RESUMEN

The purpose of our study is to determine whether the current level of transplant fellow training is sufficient to meet the future demand for liver transplantation in the United States. Historical data from the Nationwide Inpatient Samples (NIS) for the years 1998 through 2003 were used to construct an estimate of the annual number of liver transplant procedures currently being performed in the United States, and the number projected for each year through 2020. Estimates for the current and future number of surgeons performing liver transplant procedures were also constructed using the same database. The NIS database was used because current national transplant registries do not include information on the number of surgeons performing liver transplant procedures. Using historical data derived from the NIS database, we project that the estimated number of liver transplant procedures per surgeon will remain relatively stable through 2020, with each surgeon performing an average of 12.9 procedures in 2020 compared to 12.9 currently. We conclude that the relationship between demand for liver transplantation in the United States and the supply of liver transplant surgeons will remain stable over the next 15 years.

11.
Am J Transplant ; 8(8): 1614-21, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18557728

RESUMEN

Long-term survival of a pulmonary allograft is currently hampered by obliterative bronchiolitis (OB), a form of chronic rejection that is unique to lung transplantation. While tracheobronchial aspiration from gastroesophageal reflux disease (GERD) has clinically been associated with OB, no experimental model exists to investigate this problem. Using a WKY-to-F344 rat orthotopic left lung transplant model, the effects of chronic aspiration on pulmonary allograft were evaluated. Recipients received cyclosporine with or without 8 weekly aspirations of gastric fluid into the allograft. Six (66.7%) of 9 allografts with aspiration demonstrated bronchioles with surrounding monocytic infiltrates, fibrosis and loss of normal lumen anatomy, consistent with the development of OB. In contrast, none of the allografts without aspiration (n = 10) demonstrated these findings (p = 0.002). Of the grafts examined grossly, 83% of the allografts with chronic aspiration but only 20% without aspiration appeared consolidated (p = 0.013). Aspiration was associated with increased levels of IL-1 alpha, IL-1 beta, IL-6, IL-10, TNF-alpha and TGF-beta in BAL and of IL-1 alpha, IL-4 and GM-CSF in serum. This study provides experimental evidence linking chronic aspiration to the development of OB and suggests that strategies aimed at preventing aspiration-related injuries might improve outcomes in clinical lung transplantation.


Asunto(s)
Bronquiolitis Obliterante/etiología , Supervivencia de Injerto , Trasplante de Pulmón , Aspiración Respiratoria/complicaciones , Animales , Lavado Broncoalveolar , Modelos Animales de Enfermedad , Interleucinas/análisis , Masculino , Ratas , Ratas Endogámicas F344 , Ratas Endogámicas WKY , Factores de Crecimiento Transformadores/análisis , Factor de Necrosis Tumoral alfa/análisis
12.
Transplant Proc ; 37(8): 3564-6, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16298662

RESUMEN

PURPOSE: We sought to evaluate the role of recipient body mass index (BMI) on postoperative complications in patients receiving pancreas transplants. METHODS: A single-institution retrospective study of 145 consecutive patients undergoing either simultaneous kidney pancreas (SPK) or pancreas after kidney (PAK) transplantation from January 1997 through December 2003. Variables analyzed included: age, sex, BMI, number of prior transplants, cytomegalovirus status of donor and recipient, postoperative insulin resistance, complications, and overall patient and graft survival. Differences in continuous variables and dichotomous variables were evaluated using two-tailed t test and Fisher exact test, respectively. Univariate and multivariate logistic regression analyses were employed to identify predictors of overall complications following surgery. RESULTS: Obesity was defined by a BMI > or = 30. Of the 145 patients, 33 (23%) had a BMI > or = 30 and 112 (77%) had a BMI < 30. There was no significant difference in age or sex between obese and nonobese patients (P = .98 and P = .56, respectively). The type of transplantation, SPK or PAK, did not affect the complication rate (P = .36). Overall complications (infection, dehiscence, evisceration, ventral hernia, allograft failure, gangrene, necrotizing fasciitis, postoperative bleeding, or death) were significantly higher in the obese group (81% vs 40%, P < .001). Obesity was specifically associated with increased frequency of dehiscence, ventral hernia, intra-abdominal infection, gangrene, necrotizing fasciitis, and repeat laparotomy. Obese patients also had a threefold higher rate of graft pancreatitis/enteric leak. Multivariate logistic regression analysis identified age > or = 50 and BMI > or = 30 as independent predictors of overall complications following surgery (odds ratio 4.0, P = .014 and OR 6.8, P < .001, respectively). There was no difference identified between groups with regards to allograft failure, posttransplant insulin resistance, and death. CONCLUSION: Obese patients are at increased risk of overall complications following pancreas transplantation. Specifically, obese patients experience higher frequency of dehiscence, ventral hernia, intra-abdominal infection, gangrene, and necrotizing fasciitis. This study demonstrates the need for careful postoperative monitoring in the obese patient.


Asunto(s)
Obesidad/complicaciones , Trasplante de Páncreas/efectos adversos , Complicaciones Posoperatorias/epidemiología , Adulto , Femenino , Gangrena/epidemiología , Gangrena/mortalidad , Humanos , Infecciones/epidemiología , Masculino , Persona de Mediana Edad , Trasplante de Páncreas/mortalidad , Complicaciones Posoperatorias/clasificación , Reoperación/estadística & datos numéricos , Estudios Retrospectivos , Análisis de Supervivencia
13.
Proc Natl Acad Sci U S A ; 101(7): 1945-50, 2004 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-14766972

RESUMEN

Drosophila melanogaster locomotor activity responds to different seasonal conditions by thermosensitive regulation of splicing of a 3' intron in the period mRNA transcript. Here we demonstrate that the control of locomotor patterns by this mechanism is primarily light-dependent at low temperatures. At warmer temperatures, when it is vitally important for the fly to avoid midday desiccation, more stringent regulation of splicing is observed, requiring the light input received through the visual system during the day and the circadian clock at night. During the course of this study, we observed that a mutation in the no-receptor-potential-A(P41) (norpA(P41)) gene, which encodes phospholipase-C, generated an extremely high level of 3' splicing. This cannot be explained simply by the mutation's effect on the visual pathway and suggests that norpA(P41) is directly involved in thermosensitivity.


Asunto(s)
Ritmo Circadiano/fisiología , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/enzimología , Drosophila melanogaster/fisiología , Actividad Motora/fisiología , Células Fotorreceptoras de Invertebrados/metabolismo , Estaciones del Año , Fosfolipasas de Tipo C/metabolismo , Análisis de Varianza , Animales , Proteínas CLOCK , Ritmo Circadiano/efectos de la radiación , Criptocromos , Proteínas de Drosophila/genética , Drosophila melanogaster/genética , Drosophila melanogaster/efectos de la radiación , Proteínas del Ojo/genética , Proteínas del Ojo/metabolismo , Luz , Actividad Motora/genética , Mutación/genética , Proteínas Nucleares/genética , Proteínas Circadianas Period , Fosfolipasa C beta , Células Fotorreceptoras de Invertebrados/efectos de la radiación , Empalme del ARN/genética , Receptores Acoplados a Proteínas G , Temperatura , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Vías Visuales/fisiología , Vías Visuales/efectos de la radiación
14.
Expert Opin Biol Ther ; 1(1): 109-19, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11727540

RESUMEN

Diabetes mellitus is estimated to affect at least 16 million individuals in the United States and 135 million persons worldwide. It is a significant cause of morbidity and early mortality. The related expenses are astronomical with at least 15% of healthcare expenditures in the United States being used for the treatment of diabetes and its complications, a figure that approaches US$100 billion annually. The Diabetes Control and Complications Trial (DCCT) convincingly showed that intensive glucose management delays the onset and slows the progression of diabetic complications. Numerous studies have shown that pancreas transplantation not only delays the onset and progression of diabetic complications, but in some cases reverses some of the effects of diabetes. Human islet cell transplantation provides an alternative, less invasive alternative to whole organ transplantation. Human islet allotransplantation would only exacerbate the organ shortage, as recipients usually require islets from more than one pancreas. Xenotransplantation of porcine islets is a more attractive option; however, the recipient's immune response to xenografted tissue would be a formidable obstacle. Microencapsulation of the islets is a method of immunoisolation that would prevent the need for immunosuppressive drugs and the risks associated with their long-term use and have the potential to make xenoislet transplantation a clinical reality.


Asunto(s)
Trasplante de Células/métodos , Diabetes Mellitus/terapia , Islotes Pancreáticos/fisiología , Animales , Catárticos/farmacología , Humanos , Insulina/uso terapéutico , Sulfatos/farmacología , Factores de Tiempo , Trasplante Heterólogo/métodos
16.
Nutr Cancer ; 39(1): 148-53, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11588897

RESUMEN

Antioxidant micronutrients may account for the beneficial effects of fruits on human health. A direct demonstration that consumption of fruit decreases oxidative DNA damage in human cells would support this hypothesis. Kiwifruit was taken as an example of a food with putative antioxidant properties, and its effectiveness at decreasing oxidative DNA damage was assessed in ex vivo as well as in vitro tests. The comet assay (single-cell gel electrophoresis) was used to measure DNA damage in lymphocytes collected during a human supplementation trial with a single 0.5-liter drink of kiwifruit juice (with water as a control). The comet assay was also modified to assess the antioxidant effect of kiwifruit in vitro by measuring the ability of an extract to interfere with oxidative damage to DNA induced by H2O2. Ex vivo, consumption of kiwifruit led to an increased resistance of DNA to oxidative damage induced by H2O2 in isolated lymphocytes, in comparison with lymphocytes collected after a control drink of water. No effect was seen on endogenous DNA damage. In vitro, a simple extract of kiwifruit, buffered to pH 7, was more effective than a solution of vitamin C (of equivalent concentration) at protecting DNA from damage, whereas at the highest concentrations tested, neither kiwi extract nor vitamin C had a protective effect. We have demonstrated significant antioxidant activity of kiwifruit ex vivo and in vitro, not attributable entirely to the vitamin C content of the fruit. Our dual approach is appropriate for testing other fruit and vegetable products for potential antioxidant effects.


Asunto(s)
Actinidia , Antioxidantes/administración & dosificación , Daño del ADN/efectos de los fármacos , ADN/efectos de los fármacos , Frutas , Linfocitos/efectos de los fármacos , Adulto , Ácido Ascórbico/administración & dosificación , Células Cultivadas , Ensayo Cometa , ADN/metabolismo , Femenino , Humanos , Linfocitos/metabolismo , Masculino , Persona de Mediana Edad , Oxidación-Reducción , Estrés Oxidativo , Extractos Vegetales/farmacología
17.
Arch Surg ; 136(3): 276-9, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11231845

RESUMEN

HYPOTHESIS: Mechanical injury and oxidative stress caused by reoxygenation of isolated porcine islet cells result in their unresponsiveness to glucose stimulation. DESIGN: Adult pigs (weighing 25-30 kg) were anesthetized, and following intra-arterial infusion of ice-cold University of Wisconsin solution, a complete pancreatectomy was performed. The pancreatic duct was cannulated for infusion of digestion medium containing collagenase type P, 1.5 mg/mL; deoxyribonuclease I, 10 000 U; and a water-soluble analogue of vitamin E (Trolox), 1 mmol/L. After 20-minute incubations on ice, and at 37 degrees C, the pancreas was hand shaken for 1 minute, followed by filtration and separation on an automatic cell separator (COBE 2991). Islet cells, identified by dithizone staining, were perifused at 37 degrees C. RESULTS: The mean +/- SEM yield of intact purified islet cells (50-200 microm in diameter), and mostly present in clusters, was 2398 +/- 143 cells per gram (n = 12). Glucose stimulation caused a significant increase in biphasic insulin secretion in the perifusion experiments. CONCLUSION: We have developed a simple, reproducible, and reliable procedure for isolating intact and viable porcine islet cells suitable for xenotransplantation.


Asunto(s)
Glucemia/metabolismo , Supervivencia Celular/fisiología , Islotes Pancreáticos/citología , Recolección de Tejidos y Órganos , Animales , Técnicas de Cultivo , Insulina/metabolismo , Secreción de Insulina , Trasplante de Islotes Pancreáticos , Porcinos , Trasplante Heterólogo
18.
Transplantation ; 70(5): 780-3, 2000 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-11003357

RESUMEN

BACKGROUND: Advances in perioperative care and immunosuppression have enabled clinicians to broaden the indications for organ transplantation. Advanced age is no longer considered a contraindication to transplantation at most centers. Although short-term studies of elderly liver transplant recipients have demonstrated that the incidence of complications and overall patient survival are similar to those of younger adults, transplant center-specific, long-term data are not available. METHODS: From August of 1984 to September of 1997, 91 patients 60 years of age or older received primary liver transplants at the University of Wisconsin, Madison. This group of patients was compared with a group of younger adults (n=387) ranging in age from 18 to 59 years who received primary liver transplants during the same period. The most common indications for transplantation in both groups were Laennec's cirrhosis, hepatitis C, primary biliary cirrhosis, primary sclerosing cholangitis, and cryptogenic cirrhosis. There was no difference in the preoperative severity of illness between the groups. Results. The length of hospitalization was the same for both groups, and there were no significant differences in the incidence of rejection, infection (surgical or opportunistic), repeat operation, readmission, or repeat transplantation between the groups. The only significant difference identified between the groups was long-term survival. Five-year patient survival was 52% in the older group and 75% in the younger group (P<0.05). Ten-year patient survival was 35% in the older group and 60% in the younger group (P<0.05). The most common cause of late mortality in elderly liver recipients was malignancy (35.0%), whereas most of the young adult deaths were the result of infectious complications (24.2%). CONCLUSION: Although older recipients at this center did as well as younger recipients in the early years after liver transplantation, long-term survival results were not as encouraging.


Asunto(s)
Trasplante de Hígado/mortalidad , Anciano , Envejecimiento/fisiología , Causas de Muerte , Femenino , Rechazo de Injerto/epidemiología , Humanos , Trasplante de Hígado/inmunología , Masculino , Tasa de Supervivencia/tendencias , Sobrevivientes
20.
Kidney Int ; 57(5): 2129-35, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10792634

RESUMEN

BACKGROUND: Diabetic renal disease continues to be the most significant cause of end-stage renal disease (ESRD) in the United States. Renal transplantation improves diabetic ESRD patient survival; however, the diabetic state remains associated with poor patient survival. Simultaneous pancreas-kidney (SPK) transplantation can restore normoglycemia and thus may improve outcomes. METHODS: We assessed the impact of SPK on age-range-matched type 1 diabetic patients who underwent renal transplantation at a single center. The observed/expected life span and annual mortality rates (AMRs) were used as measures of survival. A Cox proportional hazards analysis was used to analyze the impact of potential variables on mortality in SPK recipients. RESULTS: SPK transplantation (N = 335) increased the observed/expected life span compared with diabetic cadaveric (DM-Cad, N = 147) and live-donor (DM-Live, N = 160) transplant recipients (P = 0.004) and significantly reduced the AMRs (SPK, 1. 5%; DM-Cad, 6.27%; DM-Live, 3.65%, P = 0.008, SPK vs. other DM). Moreover, the SPK observed/expected life span and AMR were not significantly different from that of age-range-matched nondiabetic transplant recipients (N = 492). The only variable that was significantly associated with patient survival was discharge serum creatinine (relative risk 1.16, P < or = 0.0154). CONCLUSION: These data demonstrate that SPK improves the ability for type 1 diabetic patients to live more of their expected life span. This suggests that glycemic control, even as a late intervention in a diabetic patient's lifetime, may beneficially affect survival.


Asunto(s)
Diabetes Mellitus Tipo 1/cirugía , Nefropatías Diabéticas/cirugía , Fallo Renal Crónico/cirugía , Trasplante de Riñón , Trasplante de Páncreas , Adulto , Diabetes Mellitus Tipo 1/mortalidad , Nefropatías Diabéticas/mortalidad , Femenino , Humanos , Fallo Renal Crónico/mortalidad , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA